Lenvatinib-activated NDUFA4L2/IL33/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma
Cellular Oncology · 2025
DOI: 10.1007/s13402-024-01013-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Nan Yi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Quinolines, Liver Neoplasms, Phenylurea Compounds. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Joint Construction Project of the Key Project of Medical Science and Technology of Henan Province of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
- Key Clinical Laboratory of Henan Province, Zhengzhou, 450052, China.
- Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. 790034974@qq.com.
- Key Clinical Laboratory of Henan Province, Zhengzhou, 450052, China. 790034974@qq.com.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China. gaojian@renji.com.
Förderung
- Joint Construction Project of the Key Project of Medical Science and Technology of Henan Province of China
Zitieren
APA
Yi, N., Zhang, L., Huang, X., Ma, J., & Gao, J. (2025). Lenvatinib-activated NDUFA4L2/IL33/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma. Cellular Oncology. https://doi.org/10.1007/s13402-024-01013-w
Vancouver
Yi N, Zhang L, Huang X, Ma J, Gao J. Lenvatinib-activated NDUFA4L2/IL33/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma. Cellular Oncology. 2025. doi:10.1007/s13402-024-01013-w
BibTeX
@article{Yi2025,
author = {Yi, Nan and Zhang, Lingyun and Huang, Xiangbo and Ma, Jilei and Gao, Jian},
title = {Lenvatinib-activated NDUFA4L2/IL33/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-024-01013-w}
}
EUVIMED